Emergent BioSolutions Inc.‘s (EBS) MACD indicator has entered into bearish territory with a reading of -0.0497. The Zacks #5 Rank (“Strong Sell”) stock decreased more than 1% to $16.78 in morning trade. The Zacks Consensus Estimate for the year ended December 2011 has decreased by a cent over the past two months to 57 cents per share.
To read this article on Zacks.com click here.
Zacks Investment Research
